SEARCH

SEARCH BY CITATION

References

  • Anie, K.A. & Steptoe, A. (2003) Pain, mood and opioid medication use in sickle cell disease. The Hematology Journal, 4, 7173.
  • Anie, K.A., Steptoe, A. & Bevan, D.H. (2002) Sickle cell disease: pain, coping, and quality of life in a study of adults in the UK. British Journal of Health Psychology, 7, 331344.
  • Arseneault, L., Cannon, M., Witton, J. & Murray, R.M. (2004) Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry, 184, 110117.
  • Campbell, F.A., Tramer, M.R., Carroll, D., Reynolds, D.J., Moore, R.A. & McQuay, H.J. (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. British Medical Journal, 323, 1316.
  • Clark, A.J., Ware, M.A., Yazer, E., Murray, T.J. & Lynch, M.E. (2004) Patterns of cannabis use among patients with multiple sclerosis. Neurology, 62, 20982100.
  • Claster, S. & Vichinsky, E.P. (2003) Managing sickle cell disease. British Medical Journal, 327, 151155.
  • Dampier, C., Ely, E., Brodecki, D. & O'Neal, P. (2002) Home management of pain in sickle cell disease: a daily diary study in children and adolescents. Journal of Pediatric Hematology and Oncology, 24, 643647.
  • Dansak, D.A. (1997) Medical use of recreational drugs by AIDS patients. Journal of Addiction Diseases, 16, 2530.
  • Elander, J., Lusher, J., Bevan, D. & Telfer, P. (2003) Pain management and symptoms of substance dependence among patients with sickle cell disease. Social Science and Medicine, 57, 16831696.
  • Fuggle, P., Shand, P.A., Gill, L.J. & Davies, S.C. (1996) Pain, quality of life and coping in sickle cell disease. Archives of Diseases in Childhood, 75, 199203.
  • Holdcroft, A., Smith, M., Jacklin, A., Hodgson, H., Smith, B., Newton, M. & Evans, F. (1997) Oral cannabinoids in Familial Mediterranean Fever: a case report. Anaesthesia, 52, 483488.
  • Macleod, J., Oakes, R., Copello, A., Crome, I., Egger, M., Hickman, M., Oppenkowski, T., Stokes-Lampard, H. & Davey Smith, G. (2004) Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal general population studies. Lancet, 363, 15791588.
  • Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E., Mechoulam, R. & Feldman, M. (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences of the United States of America, 97, 95619566.
  • Mateo, I., Pinedo, A., Gomex-Beldarrain, M., Basterretxea, J.M. & Garcia-Monco, J.C. (2005) Recurrent stroke associated with cannabis use. Journal of Neurology, Neurosurgery and Psychiatry, 76, 435437.
  • Maxwell, K., Streetly, A. & Bevan, D. (1999) Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. British Medical Journal, 318, 15851590.
  • Noyes, Jr, R., Brunk, S.F., Avery, D.A. & Canter, A.C. (1975a) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clinical Pharmacology and Therapeutics, 18, 8489.
  • Noyes, Jr, R., Brunk, S.F., Baram, D.A. & Canter, A. (1975b) Analgesic effect of delta-9-tetrahydrocannabinol. Journal of Clinical Pharmacology, 15, 139143.
  • Page, S.A., Verhoef, M.J., Stebbins, R.A., Metz, L.M. & Levy, J.C. (2003) Cannabis use as described by people with multiple sclerosis. Canadian Journal of Neurological Science, 30, 201205.
  • Prestage, G.S., Kippax, M. & Grulich, A. (1996) Use of treatments and health enhancement behaviours among HIV positive men in a cohort of homosexually active men. XI International Conference on AIDS. Vancouver, BC, Canada.
  • Ramsay, M., Baker, P., Goulden, C., Sharp, C. & Sondhi, A. (2001) Drug misuse declared in 2000: results from the British Crime Survey. In: Home Office Research Study 224. Home Office Research, Development and Statistics Directorate, Home Office, London.
  • Rees, D.C., Olujohungbe, A.D., Parker, N.E., Stephens, A.D., Telfer, P. & Wright, J. for the Committee for Standards in Haematology (2003) Guidelines for the management of acute painful crisis in sickle cell disease. British Journal of Haematology, 120, 744752.
  • Shapiro, B.S., Benjamin, L.J., Payne, R. & Heidrich, G. (1997) Sickle cell-related pain: perceptions of medical practitioners. Journal of Pain and Symptom Management, 14, 168174.
  • Sidney, S. (2001) Marijuana use in HIV positive and AIDS patients: results of an anonymous mail survey. In: Cannabis Therapeutics in HIV/AIDS (ed. by E. Russo), pp. 3541. The Howarth Press, Binghamton, NY, USA.
  • Svendsen, K., Jensen, T.S. & Bach, F.W. (2004) Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. British Medical Journal, 329, 253.
  • Wade, D.T., Robson, P., House, H., Makela, P. & Aram, J. (2003) A preliminary controlled study to determine whether whole-plant cannabis extracts can improve neurogenic symptoms. Clinical Rehabilitation, 17, 2129.
  • Walker, M.J., Hohmann, A.G., Martin, W.J., Strangman, N.M., Huang, S.M. & Tsou, K. (1999) The neurobiology of cannabinoid analgesia. Life Sciences, 65, 665673.
  • Ware, M.A., Doyle, C.R., Woods, R., Lynch, M.E. & Clark, A.J. (2003) Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain, 102, 211216.
  • Welch, S. & Eads, M. (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Research, 848, 183190.
  • Wesner, B. (1996) The medical marijuana issue among PWAs: reports of therapeutic use and attitudes towards legal reform. Working Paper No 3, Working Paper Series. Drug Research Unit, Social Science Research Institute, University of Hawaii.
  • Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A. & Holdcroft, A. (2005) Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29, 358367.
  • Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A. & Thompson, A. (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. The Lancet, 362, 15171526.